Henry Wilke Murray, M.D.

Infectious Disease

Publications

Dr. Murray has published 216 original research and clinical publications and review articles, 10 invited editorials and 64 books and book chapters. Recent selected publications include:

Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 366:1561, 2005.

Sundar S, Maurya R, Singh RK, Bharti K, Chakravarty J, Parekh A, Rai M, Kumar K, Murray HW. Rapid noninvasive diagnosis in Indian visceral leishmaniasis: comparison of two strips formats in detection of anti-K39 antibody. J Clin Microbiol 44:251, 2006.

Murray HW, Xiang Z, Ma X. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. Am J Trop Med Hyg 74:1013, 2006.

Murray HW, Tsai CW, Liu J, Ma X. Responses to Leishmania donovani in mice deficient in IL-12, IL-12/IL-23 or IL-18. Infect Immun 74:4370, 2006.

Murray HW, Tsai CW, Liu J, Ma X. Visceral Leishmania donovani infection in IL-13-/- mice. Infect Immun 74:2487, 2006.

Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, Murray HW. Amphotericin B treatment in Indian visceral leishmaniasis: response to 15 daily vs. alternate-day infusions. Clin Infect Dis 45:556, 2007.

Miro JM, Murray HW, Katlama C. Toxoplasmosis. In AIDS Therapy (eds. R. Dolin, H. Masur, M. Saag), Churchill Livingstone, Inc., 3rd Edition, New York, chapter 37, 2008

Sundar S, Rai M, Chakravarty J, Agrawal D, Agrawal N, Vaillant M, Olliaro P, Murray HW. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by with short-course miltefosine. Clin Infect Dis 47:1000, 2008.

Murray HW. Accelerated control of visceral Leishmania donovani infection in IL-6-/- mice. Infect Immun 76:4088, 2008.

Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for Indian visceral leishmaniasis. N Eng J Med 362: 504, 2010.

Fusco DN, Downs JN, Satlin MJ, Pahuja M, Ramos L, Fleckenstein L, Murray HW. Non-oral ivermectin treatment for disseminated strongyloidiasis. Am J Trop Med Hyg 83:879, 2010.

Murray HW. Treatment of visceral leishmaniasis in 2010: direction from Bihar State,

India. Future Microbiol 5:1301, 2010.

Leyritana KT, Saniel MC, Carpo BG, Murray HW. New World cutaneous leishmaniasis in a traveler: first documented case in the Philippines. Acta Medica Philippina 45:73, 2011.

Murray HW. Leishmaniasis in the United States: treatment in 2012. Amer J Trop Med Hyg 86:434, 2012.

Murray HW, Zhang Y, Zhang Y, Raman VS, Reed SG, Ma X. Regulatory actions of TLR2 and TLR4 in Leishmania donovani infection in the liver. Infect Immun 81:2318, 2013.

Back to topBack To Top